Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

BioTheryX patents IL-1beta, IL-6, IL-2 and TNF-alpha production inhibitors

March 20, 2019

Bridge Medicines signs agreement with Weill Cornell Medicine to develop novel S1P receptor modulator

March 12, 2019

STING innate immune protein induces autophagy

March 11, 2019

XW Laboratories discloses ROS production inhibitors

March 7, 2019

Sunshine Lake Pharma prepares and tests MAP3K5 inhibitors

March 6, 2019

Sunshine Lake Pharma identifies new semicarbazide-sensitive amine oxidase inhibitors

Feb. 28, 2019

Generation of a novel nucleoside inhibitor for the treatment of ischemia-reperfusion injury

Feb. 28, 2019

Targeting DEFA1/DEFA3 ameliorates sepsis severity in mice

Feb. 27, 2019

Nicotinamide N-methyltransferase inhibitor enhances aged muscle regeneration

Feb. 27, 2019

Size matters for cell prowess

Feb. 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...